Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

TAURINE CRS (15 MG)

TAURINE CRS (15 MG)

ND

DISCOVER
URSODOXICOLTAURINE DIHYDRATE CRS (25 MG)

URSODOXICOLTAURINE DIHYDRATE CRS (25 MG)

ND

DISCOVER
ETRAVIRINE CRS (220 MG)

ETRAVIRINE CRS (220 MG)

ND

DISCOVER
DEFERASIROX FOR SYSTEM SUITABILITY A CRS (0.502 MG)

DEFERASIROX FOR SYSTEM SUITABILITY A CRS (0.502 MG)

ND

DISCOVER
ETRAVIRINE FOR SYSTEM SUITABILITY CRS (10 MG)

ETRAVIRINE FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
SINIGRIN POTASSIUM CRS (10 MG)

SINIGRIN POTASSIUM CRS (10 MG)

ND

DISCOVER
ETRAVIRINE FOR PEAK IDENTIFICATION CRS (10 MG)

ETRAVIRINE FOR PEAK IDENTIFICATION CRS (10 MG)

ND

DISCOVER
COLCHICINE FOR SYSTEM SUITABILITY B CRS (10 MG)

COLCHICINE FOR SYSTEM SUITABILITY B CRS (10 MG)

ND

DISCOVER
PEFLOXACIN FOR SYSTEM SUITABILITY CRS (1.001 MG)

PEFLOXACIN FOR SYSTEM SUITABILITY CRS (1.001 MG)

ND

DISCOVER
CHLOROXYLENOL CRS (160 MG)

CHLOROXYLENOL CRS (160 MG)

ND

DISCOVER
CHLOROXYLENOL FOR SYSTEM SUITABILITY CRS (55 MG)

CHLOROXYLENOL FOR SYSTEM SUITABILITY CRS (55 MG)

ND

DISCOVER
POLYSORBATE  20 CRS (100 MG)

POLYSORBATE 20 CRS (100 MG)

ND

DISCOVER